Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Scialla

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
American Journal of Clinical Pathology|September 1, 1985
Heparin monitoring by activated partial thromboplastin time. Comparison of ex vivo measurement and in vitro standardizationS J Scialla
The New England Journal of Medicine|January 6, 1994
Case 27-1993: cerebral vasculitisS J Scialla
The Journal of Clinical Investigation|October 1, 1981
Isolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasmaH Saito, S J Scialla
Pennsylvania Medicine|May 1, 1987
Jonathan Wainwright--pioneer in cancer controlS J Scialla, S Harper
Postgraduate Medicine|October 1, 1982
Anemia and food fadismP G Decker, S J Scialla
JAMA|May 31, 1976
Basal-cell carcinoma. A case unmasked by systemic fluorouracil therapyS J Scialla, R A Miskoff
Military Medicine|April 1, 1982
Blood coagulation profiles in patients with carcinoma of the lungE Perlin, S J Scialla, R Connor
Archives of Physical Medicine and Rehabilitation|May 12, 2000
Functional recovery in cancer rehabilitationR P Cole, S J Scialla, L Bednarz
Cancer|April 1, 1982
Endobronchial metastatic plasmacytomaM F Tenholder, S J Scialla, G Weisbaum
Cancer|February 1, 1978
Acquired platelet dysfunction following mithramycin therapyD J Ahr, S J Scialla, D B Kimbali
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
American Journal of Clinical Pathology|September 1, 1985
Heparin monitoring by activated partial thromboplastin time. Comparison of ex vivo measurement and in vitro standardizationS J Scialla
The New England Journal of Medicine|January 6, 1994
Case 27-1993: cerebral vasculitisS J Scialla
The Journal of Clinical Investigation|October 1, 1981
Isolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasmaH Saito, S J Scialla
Pennsylvania Medicine|May 1, 1987
Jonathan Wainwright--pioneer in cancer controlS J Scialla, S Harper
Postgraduate Medicine|October 1, 1982
Anemia and food fadismP G Decker, S J Scialla
JAMA|May 31, 1976
Basal-cell carcinoma. A case unmasked by systemic fluorouracil therapyS J Scialla, R A Miskoff
Military Medicine|April 1, 1982
Blood coagulation profiles in patients with carcinoma of the lungE Perlin, S J Scialla, R Connor
Archives of Physical Medicine and Rehabilitation|May 12, 2000
Functional recovery in cancer rehabilitationR P Cole, S J Scialla, L Bednarz
Cancer|April 1, 1982
Endobronchial metastatic plasmacytomaM F Tenholder, S J Scialla, G Weisbaum
Cancer|February 1, 1978
Acquired platelet dysfunction following mithramycin therapyD J Ahr, S J Scialla, D B Kimbali
Pageof 2